JOHN WILEY & SONS, INC. (WLY): what the price assumes

In the published model solve dated 2026-Q2, anchored at $54.49, JOHN WILEY & SONS, INC. (WLY) is priced for -1.7% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/WLY

Headline

FieldValue
TickerWLY
CompanyJOHN WILEY & SONS, INC.
Current price$54.49/sh
CompositionResearch Publishing 58% / Research Solutions 10% / Academic 19% / Professional 14%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)8.1%
Operating margin today16.5%
Margin compression (value-band)-8.4pp
Implied growth-1.7%
Multiple paid13x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 8.4% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~5.9pp.

How unusual the bet is: within-range

ReferenceValue
vs own history+0.02σ
cohort percentile (of 221 peers)13
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and relative-multiple and growth-DCF value, while earnings-power lands below the price. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.20x5expensive
Earnings1.63x5expensive
Relative0.72x2justifies
Growth1.20x4expensive

Families that justify the price: Asset, Relative, Growth Families that call it expensive: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.5%); the inversion above states its own rate.

Per-Model Detail (n=16)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$42.461.28xyesFCF base $0.2B, growth -0% (input: historical growth), terminal g 0.5%, WACC 7.5%, 5yr projection
DCF Exit MultipleGrowth$54.361.00xyesExit EV/EBITDA: 6.5x / 8.5x / 10.5x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative——noP/E 18x (static sector reference · 2026-04), scenarios: 15.3x / 18.0x / 20.7x (bear / base = reference held flat / bull), EV/EBITDA 12x
Simple DDMGrowth——no—
Two-Stage DDMGrowth$48.641.12xyesStage 1: 20% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$45.501.20xyesBV/sh $16.11, ROE (TTM) 26.1%, ke 9.3%
Two-Stage Excess ReturnAsset$77.260.71xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$34.911.56xyesRev $1.7B, growth -0% (input: historical growth; tapered), Terminal P/S: 1.5x / 1.7x / 2.0x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$49.921.09xyesEPS $4.16, growth 2% (input: historical EPS growth), PEG=6.47 (Overvalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings$33.351.63xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.23B × (1−21%) / WACC 7.5% → EPV (no growth)
Residual IncomeAsset$67.800.80xyesBV $16.11 + 5yr PV of (ROE (TTM) 26.1% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$38.831.40xyes√(22.5 × EPS $4.16 × BVPS $16.11) — Graham's conservative floor
EV/EBITDA RelativeRelative——noEBITDA $0.42B × sector EV/EBITDA 12.0x
FCF YieldEarnings$29.581.84xyesFCF $209.4M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$25.352.15xyesSBC-adj FCF $0.19B (FCF $0.21B − SBC $0.02B) capitalized at Kₑ
Ben Graham FormulaEarnings$134.230.41xyesEPS $4.16 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$12.064.52xyesBV $16.11 × (ROIC 5.6% / WACC 7.5%)
P/Sales SectorRelative——noRevenue $1.68B × sector P/S 2.5x
PEG Fair ValueRelative$156.000.35xyesEPS $4.16 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$44.971.21xyesEPS $4.16 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Researchoperatingenterprise$1.1b—withheldunresolved no unit value
Learningoperatingenterprise$584.8m—withheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$607.7m
Net debt / NOPAT (after-tax)2.78x
Net debt / operating income (pre-tax)2.20x
Interest coverage6.3x
Share count CAGR (buyback)-1.7%
Burning cashno

Bullet Takeaways

Bull Case

The balance sheet is the right place to start with Wiley, because it tells you how much confidence management has earned the right to. At fiscal 2026 year-end, net debt-to-EBITDA improved to 1.4 times from 1.8 times, net debt fell to about 608 million dollars, and free cash flow reached 195 million dollars, up 55 percent year over year. A company deleveraging while cash flow surges is a company whose underlying economics are strengthening, not stretching. Wiley underlined that confidence by raising its dividend for the 33rd consecutive year, to about 1.43 dollars annually, a streak few businesses sustain and none sustain by accident. A 33-year dividend-growth record paired with a falling leverage ratio is the signature of a business that generates dependable cash and shares it.

The cash is coming from a research-publishing franchise that just posted record profitability. Full-year fiscal 2026 revenue was 1.68 billion dollars, but operating income rose 25 percent to 277 million dollars and diluted EPS reached 4.16 dollars against 1.53 a year earlier, with an adjusted operating-income margin at a record 17.7 percent. The Research segment generated 1.13 billion dollars, up 5 percent, on gold open-access growth and a new revenue line: AI licensing. AI-licensing revenue reached 49.1 million dollars, up 23 percent, with cumulative lifetime AI revenue now above 110 million dollars, as Wiley converted its peer-reviewed content archive into a licensable asset.

That AI pivot is the bull's forward story. Rather than being disrupted by large language models, Wiley is selling them training and reference content, signing deals with IQVIA and OpenEvidence in healthcare AI and an agreement with Anthropic to integrate peer-reviewed content into the Claude platform. A century-and-a-half of curated, authoritative scientific content is exactly the scarce, high-trust corpus AI developers need and cannot easily replicate. Return on equity runs above 20 percent, the valuation sits within range rather than stretched, and the inversion implies the price embeds only about 1 percent annual operating growth. For a deleveraging dividend compounder with a new high-margin AI-licensing tailwind, that is a low bar to clear.

Bear Case

The structural truth a Wiley holder would rather not face is that the core business, charging for access to research, is the thing the open-access movement and AI are both built to dismantle. For decades Wiley earned its margins because universities and libraries had to pay for subscription journals. The model that is replacing it, author-funded open access, shifts who pays and compresses the per-article economics, and Wiley is participating because it has no choice: Research Publishing's growth now leans on a 28 percent increase in author-funded open access and a 200-plus-journal open-access series. The revenue may hold for now, but the pricing power that produced the historic margins is migrating to a model where the content is free to read, which is a slow erosion of the moat rather than a sudden break.

AI is the second blade of the same scissors. The AI-licensing revenue the bull case celebrates is a one-time-feeling windfall that may not recur at the same scale: once a model has trained on Wiley's archive, the marginal value of re-licensing the same corpus falls, and at 49 million dollars it is a small fraction of the 1.68 billion dollar top line. More dangerously, the same AI that pays Wiley for content today is learning to synthesize and summarize research, which over time reduces the need to access the underlying journal article at all. A company licensing its archive to the technology most likely to disintermediate its core product is monetizing the present at some cost to the future.

The competitive and legal backdrop adds pressure. Wiley competes with ProQuest, McGraw Hill, and Cambridge University Press in a consolidating, slow-growth industry, and in 2024 it was named alongside five other academic publishers in a proposed antitrust class action over journal-publishing practices, an overhang that speaks to regulatory scrutiny of the very pricing model the business depends on. Total revenue was flat for the year, and the growth-DCF and zero-growth earnings-power frames both read the price as expensive on current normalized earnings, with the earnings-power value well below the price. The dividend is secure and the balance sheet is sound, but an investor is paying a full multiple for a business whose two growth engines, open access and AI licensing, each carry the seed of the core franchise's decline.

Valuation

Wiley prices like a mature, cash-generative publisher whose value rests on durable earnings rather than growth, and the X-ray bears that out. The growth-DCF reads are mixed, with the exit-multiple version near the price and the perpetual-growth version below it because trailing revenue growth has been slightly negative. The dissent is the earnings-power frame: capitalizing normalized EBIT with no growth produces a value near 25 dollars, well below the price, which says the current price is not justified by zero-growth earnings alone and needs the modest growth or the multiple to hold.

Inverting the price makes the embedded bet explicit and modest. At the current level the market is paying about 14.5 times company-wide operating income, which implies company-wide operating growth of only about 1 percent a year for five years. That is a low bar, and each one-percentage-point change in the cost of capital moves the implied growth by roughly 6 points, so treat it directionally. The point is that Wiley is not priced for a turnaround or a breakout; it is priced for near-stability, which a deleveraging, dividend-raising publisher can plausibly deliver.

The synthesis is that the valuation is fair rather than cheap. The asset and earnings frames anchor it near the current price, the dividend yield near 3.7 percent provides a real cash return while you wait, and the implied 1 percent growth leaves room for the AI-licensing and open-access lines to surprise modestly to the upside. The risk is captured by the earnings-power dissent: if the core subscription economics erode faster than the new lines grow, normalized earnings drift down and the price re-rates toward that lower earnings-power anchor. This is a hold-for-the-dividend-and-stability name with optionality on AI, valued accordingly, not a value bargain.

Catalysts

The clearest forward catalyst is the durability of the AI-licensing line. AI-licensing revenue reached 49.1 million dollars in fiscal 2026, and the question each quarter is whether new agreements, after the Anthropic, IQVIA, and OpenEvidence deals, keep that line growing or whether it plateaus once major models have trained on the archive. Management guided fiscal 2027 to low-to-mid-single-digit revenue growth, an adjusted EBITDA margin of 25.5 to 26.5 percent, adjusted EPS of 3.90 to 4.35 dollars, and free cash flow near 200 million dollars, so each print is a test of whether the record margins hold as the revenue mix shifts toward open access.

The second catalyst is capital allocation. Wiley acquired Emerald Publishing for 452 million dollars in cash, so the integration and return on that deal are worth tracking, as is the pace of any further deleveraging or buyback against the improved balance sheet. The dividend, now in its 33rd year of increases, is itself a recurring signal of management's cash-flow confidence. On the risk side, developments in the 2024 antitrust class action against academic publishers and any shift in library or funder open-access policy are slower-moving catalysts that bear on the core pricing model.

Sources: Wiley FY2026 record margins and AI-focused shift, simplywall.st; AI demand drives Wiley results, newsroom.wiley.com; Wiley boosts FY2026 EPS, free cash flow and 2027 guidance, stocktitan.net; Wiley acquires Emerald Publishing in 452M cash transaction, stocktitan.net.

Peer Cohorts (Per Segment, With Filing Citations)

Research (reported)

Learning (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive WLY report on boothcheck